From: Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers
miRNA | miRNA expression up or down in BRCA1 vs. sporadic cancers | Fold change miRNA | adjusted p value (BRCA1 vs. sporadic) | Predicted target gene | IPX expression up or down in BRCA1 vs. sporadic cancers | Positive IPX in BRCA1, n (%) | Positive IPX in sporadic, n (%) | p value (chi square) positive or negative on IPX | p value (Mann–Whitney) on IPX score out of 7 |
---|---|---|---|---|---|---|---|---|---|
hsa-miR-509-5p | Up | 2.53 | 0.004 | FOXP1 | Down | 6 (30 %) | 37 (76 %) | <0.001 | <0.001 |
hsa-miR-1285 | Up | 2.68 | 0.042 | ||||||
hsa-miR-1826 | Up | 3.02 | <0.001 | ||||||
hsa-miR-220b | Up | 3.76 | <0.001 | ||||||
hsa-miR-1826 | Up | 3.02 | <0.001 | Cyclin D1 | Down | 8 (36 %) | 30 (65 %) | 0.025 | 0.004 |
hsa-miR-576-3p | Up | 3.26 | 0.001 | ||||||
hsa-miR-638 | Up | 3.04 | 0.036 | ||||||
hsa-miR-30c-1* | Up | 4.51 | <0.001 | NRP1 | Down | 2 (10 %) | 23 (50 %) | 0.002 | 0.003 |
hsa-miR-1285 | Up | 2.69 | 0.043 | ||||||
hsa-miR-129-3p | Up | 6.03 | <0.001 | ||||||
hsa-miR-29a* | Down | 3.12 | <0.001 | CD99 | Up | 17 (85 %) | 7 (37 %) | 0.002 | 0.005 |
hsa-miR-130b* | Down | 2.95 | <0.006 | ||||||
hsa-miR-132* | Down | 2.48 | 0.024 | ||||||
hsa-miR-340* | Down | 3.09 | 0.028 |